(Q43952782)

28 November 2017

title

Characterization of currently marketed heparin products: key tests for quality assurance (English)

1 reference

28 November 2017

1 reference

David A Keire

1

0 references

author name string

Hongping Ye

2

1 reference

28 November 2017

Michael L Trehy

3

1 reference

28 November 2017

Wei Ye

4

1 reference

28 November 2017

Richard E Kolinski

5

1 reference

28 November 2017

Benjamin J Westenberger

6

1 reference

28 November 2017

Lucinda F Buhse

7

1 reference

28 November 2017

Moheb Nasr

8

1 reference

28 November 2017

Ali Al-Hakim

9

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

Analytical and Bioanalytical Chemistry

28 November 2017

published in

1 reference

28 November 2017

volume

399

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

581-591

1 reference

Lessons learned from the contamination of heparin

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Heparin and heparan sulfate: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Essentials of anticoagulation in hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

The FDA and safety--beyond the heparin crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Contaminated heparin associated with adverse clinical events and activation of the contact system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Mapping and quantification of the major oligosaccharide components of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Enzymatic redesigning of biologically active heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Conformation and dynamics of heparin and heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

N.m.r. and molecular-modelling studies of the solution conformation of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Preparation and anticoagulant activity of fully O-sulphonated glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Orthogonal analytical approaches to detect potential contaminants in heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Quantitative determination of disaccharide content in digested unfragmented heparin and low molecular weight heparin by direct-infusion electrospray mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

Glycosaminoglycan origin and structure revealed by multivariate analysis of NMR and CD spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-010-4023-Y

10.1007/S00216-010-4023-Y

21 January 2018

Identifiers

DOI

1 reference

release_bacozedurncu5c5collz5alqgq

28 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bacozedurncu5c5collz5alqgq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference